2-(4-acetylpiperazin-1-yl)-N-(2-hydroxy-2-(4-(trifluoromethyl)phenyl)ethyl)-2-oxoacetamide结构式
|
常用名 | 2-(4-acetylpiperazin-1-yl)-N-(2-hydroxy-2-(4-(trifluoromethyl)phenyl)ethyl)-2-oxoacetamide | 英文名 | 2-(4-acetylpiperazin-1-yl)-N-(2-hydroxy-2-(4-(trifluoromethyl)phenyl)ethyl)-2-oxoacetamide |
|---|---|---|---|---|
| CAS号 | 1351622-00-8 | 分子量 | 387.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C17H20F3N3O4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-(4-acetylpiperazin-1-yl)-N-(2-hydroxy-2-(4-(trifluoromethyl)phenyl)ethyl)-2-oxoacetamide |
|---|
| 分子式 | C17H20F3N3O4 |
|---|---|
| 分子量 | 387.4 |
| InChIKey | DZFRYBBADGJDRI-UHFFFAOYSA-N |
| SMILES | CC(=O)N1CCN(C(=O)C(=O)NCC(O)c2ccc(C(F)(F)F)cc2)CC1 |
|
实验名称:Modulation of AMPAR-stargazin complexes
来源:Vanderbilt Screening Center for GPCRs, Ion Channels and Transporters
靶标:Stargazin (mouse)
External Id:WaveGuideAssay:441
|